GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Deferred Tax

GSK (MEX:GSK N) Deferred Tax : MXN9,796 Mil (TTM As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is GSK Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

GSK's change in deferred tax for the three months ended in Sep. 2024 was MXN-26 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was MXN9,796 Mil.

GSK Deferred Tax Historical Data

The historical data trend for GSK's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Deferred Tax Chart

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23,556.46 1,791.35 2,264.18 16,788.88 16,243.71

GSK Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,540.42 -408.24 5,778.11 4,451.83 -26.05

GSK Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN9,796 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Deferred Tax Related Terms

Thank you for viewing the detailed overview of GSK's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Deferred Tax
Comparable Companies
LSE:AZN LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN AMGN PFE XPAR:SAN BMY GILD TSE:4519 TSE:4568 SHSE:600276 TSE:4578 BIIB XTER:BAYN SHSE:600436
Traded in Other Exchanges
GLAXF:USA GSK:USA GSK1:Mexico GSKl:UK GSK:UK GS70:Germany GS71:Germany GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina
Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
Website
https://www.gsk.com
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines